{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/peripheral-arterial-disease/","result":{"data":{"firstChapter":{"id":"9e988871-ea98-52a6-bb9d-910e22b3a6dd","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field ab28c6c1-6129-4d50-9839-2a8e5f0fca25 --><h1>Peripheral arterial disease: Summary</h1><!-- end field ab28c6c1-6129-4d50-9839-2a8e5f0fca25 -->","htmlStringContent":"<!-- begin item c3a12d82-32b0-48db-aac1-bf6de4b2d884 --><!-- begin field 8b7d087c-7f7b-4f52-b84b-9e3b2cea100c --><ul><li>Peripheral arterial disease is a term used to describe a narrowing or occlusion of the peripheral arteries, affecting the blood supply to the lower limbs.<ul><li>Acute limb ischaemia is a sudden decrease in limb perfusion that threatens limb viability. In acute limb ischaemia, decreased perfusion and symptoms and signs develop over less than 2 weeks.</li><li>Chronic limb ischaemia can present as intermittent claudication (diminished circulation leads to pain in the lower limb on walking or exercise that is relieved by rest) or critical limb ischaemia (circulation is so severely impaired that there is an imminent risk of limb loss). Chronic limb-threatening ischaemia is a more recent term describing clinical patterns with threatened limb viability related to several factors. It is characterised by chronic, inadequate tissue perfusion at rest and is defined by ischaemic rest pain with or without tissue loss.</li></ul></li><li>Peripheral arterial disease of the lower limbs is most commonly caused by atherosclerosis which narrows the affected arteries. This limits blood flow to the affected limb. </li><li>Acute limb ischaemia is caused by a sudden reduction in arterial perfusion of the limb, most commonly due to thrombosis within a diseased artery when an atherosclerotic plaque ruptures.</li><li>The principal risk factors for peripheral arterial disease are smoking and diabetes mellitus.</li><li>Acute limb ischaemia should be suspected when there is a sudden onset of leg pain or a sudden deterioration in claudication, associated with a loss of pulses and pallor. There may be features such as coldness and cyanosis of the limb, or loss of muscular power and sensation (these may be subtle or absent). <ul><li>If acute limb ischaemia is suspected, emergency assessment by a vascular specialist should be arranged.</li></ul></li><li>Chronic limb ischaemia should be suspected when there is progressive development of a cramp-like pain in the calf, thigh, or buttock on walking which is relieved by resting; unexplained foot or leg pain; or non-healing wounds on the lower limb. However, some people present with atypical symptoms.<ul><li>Diagnosis of chronic limb ischaemia is based on the presence of typical clinical features and measurement of the ankle brachial pressure index (ABPI).</li></ul></li><li>If the person has critical limb ischaemia, interventions should include:<ul><li>Management of cardiovascular risk, including advice on smoking cessation if applicable.</li><li>Urgent referral to a vascular multidisciplinary team.</li><li>Management of pain.</li><li>Advice on peripheral arterial disease, foot care, and driving.</li></ul></li><li>If the person has intermittent claudication, management should include:<ul><li>Management of cardiovascular risk, including advice on smoking cessation if applicable.</li><li>Offering a supervised exercise programme, if available. Unsupervised exercise may be an option, if this is unavailable.</li><li>Referral for consideration of angioplasty or bypass surgery when advice on the benefits of modifying risk factors has been reinforced and a supervised exercise programme has been tried without a satisfactory improvement in symptoms.</li><li>Consideration of prescribing naftidrofuryl oxalate if supervised exercise has not led to a satisfactory improvement, and the person prefers not to be referred for consideration of angioplasty or bypass surgery.</li><li>Advice on peripheral arterial disease and driving.</li></ul></li></ul><!-- end field 8b7d087c-7f7b-4f52-b84b-9e3b2cea100c --><!-- end item c3a12d82-32b0-48db-aac1-bf6de4b2d884 -->","topic":{"id":"fff7e03a-2313-5ab5-b744-9c6bba67aa6b","topicId":"deeaf796-d620-42bf-903e-a43ff99b1d1d","topicName":"Peripheral arterial disease","slug":"peripheral-arterial-disease","aliases":[],"chapters":[{"id":"9e988871-ea98-52a6-bb9d-910e22b3a6dd","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"81e6bfaf-7c78-52e2-b11d-8e2315ebe9e4","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"fee65eb3-86d0-571b-9815-f9407ec29fa7","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"239ddbef-73a4-5941-9dc8-52d73689e140","slug":"changes","fullItemName":"Changes"},{"id":"39825e21-a7b7-573c-86a7-fd5d87a847d3","slug":"update","fullItemName":"Update"}]},{"id":"da348d6d-4102-5de5-b9be-d28e7c83e8d0","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"c0f3f64c-323d-5c10-b5ff-9df793eab0d8","slug":"goals","fullItemName":"Goals"},{"id":"504b7741-50ac-5c4c-ac51-ea56d8cc4c46","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"a7e09ccb-6701-5658-a01c-52a02d7f9f80","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"a54b63f6-0b42-5584-91e8-027e613f7246","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"f6168c43-2e36-5e1d-bb44-04674d098b73","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"67399dd0-adb5-5b36-a616-cfc0605ebe52","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"9c30093e-b7fa-5c0f-84d0-465bf0768823","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"8f766fdc-ff98-5227-9d99-fe65802aaaca","slug":"definition","fullItemName":"Definition"},{"id":"4c33be40-568c-527a-8936-a79726b11e66","slug":"causes","fullItemName":"Causes"},{"id":"b8817533-a2e9-531b-9c51-d1c3da17b2ef","slug":"prevalence","fullItemName":"Prevalence"},{"id":"ea6fdfd8-a5f7-52de-ac19-8a05fd53556f","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"cdbbc165-3643-5f50-8f32-9fc5504ba2ef","slug":"complications","fullItemName":"Complications"},{"id":"59787aa9-8de0-5efd-b54e-2d72c75845a5","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"59e978dc-e4bc-574d-a047-413f87ec6b3d","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"ea4a531c-cf38-5e54-85d9-1f845bf7582f","slug":"when-to-suspect","fullItemName":"When to suspect"},{"id":"ebe23574-b6e5-5812-816c-6955392cee34","slug":"assessment","fullItemName":"Assessment"},{"id":"c501646c-c9a8-5372-ae9c-c0aab453c6e5","slug":"features-of-acute-limb-ischaemia","fullItemName":"Features of acute limb ischaemia"},{"id":"fdc33cb6-26a1-58c3-8eab-79d69745d871","slug":"features-of-intermittent-claudication-critical-limb-ischaemia","fullItemName":"Features of intermittent claudication and critical limb ischaemia"},{"id":"8c98aa45-6aef-5b47-a997-e9eeec827356","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"04fcdfca-c3cb-56b4-a18e-535c5a54e1a9","slug":"management","fullItemName":"Management","subChapters":[{"id":"fb3fcf0a-56a8-5693-b5ef-75e12c6f1f11","slug":"acute-limb-ischaemia","fullItemName":"Scenario: Acute limb ischaemia"},{"id":"d89d9e21-f892-533e-a3b8-e5649a205398","slug":"critical-limb-ischaemia","fullItemName":"Scenario: Critical limb ischaemia"},{"id":"357ee79f-9fa4-57e7-abd7-7881201f1629","slug":"intermittent-claudication","fullItemName":"Scenario: Intermittent claudication"}]},{"id":"da28584d-59b4-5a06-9357-9484a9bf93cc","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"e3ab00c1-43b9-58c7-a1c4-44198627e4ab","slug":"naftidrofuryl-oxalate","fullItemName":"Naftidrofuryl oxalate"},{"id":"bb79b6c3-de22-58b3-9244-5ae82a6133ad","slug":"paracetamol-weak-opioids","fullItemName":"Paracetamol and weak opioids"}]},{"id":"1545d985-832b-5a4a-abc9-bd7f0c21b754","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"049d6682-f78d-5c05-bdfb-1dbd5e91b017","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"58d7e6c5-f97f-507d-b627-87ab85bde479","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"574b8e96-33b9-5191-81dd-f415c704abf9","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"f3df8039-73c2-5c30-b7e8-2566977e32dc","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"d466274b-a2ab-58f1-badc-abfed7066e4f","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"aaed3513-3a59-5991-8410-2c4446539abd","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"74346084-c291-5a06-ac3d-a0ae85243940","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"fff7e03a-2313-5ab5-b744-9c6bba67aa6b","topicId":"deeaf796-d620-42bf-903e-a43ff99b1d1d","topicName":"Peripheral arterial disease","slug":"peripheral-arterial-disease","aliases":[],"topicSummary":"The term peripheral arterial disease is a narrowing or occlusion of the peripheral arteries affecting the blood supply to the lower limbs.","lastRevised":"Last revised in September 2019","nextPlannedReviewBy":"2024-01-01T00:00:00+00:00","nextPlannedReviewByDateTime":"2024-01","nextPlannedReviewByDisplay":"January 2024","specialities":[{"id":"fe645ae3-9536-5dfb-8c84-285b62195550","name":"Cardiovascular","slug":"cardiovascular"}],"chapters":[{"id":"9e988871-ea98-52a6-bb9d-910e22b3a6dd","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"81e6bfaf-7c78-52e2-b11d-8e2315ebe9e4","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"fee65eb3-86d0-571b-9815-f9407ec29fa7","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"239ddbef-73a4-5941-9dc8-52d73689e140","slug":"changes","fullItemName":"Changes"},{"id":"39825e21-a7b7-573c-86a7-fd5d87a847d3","slug":"update","fullItemName":"Update"}]},{"id":"da348d6d-4102-5de5-b9be-d28e7c83e8d0","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"c0f3f64c-323d-5c10-b5ff-9df793eab0d8","slug":"goals","fullItemName":"Goals"},{"id":"504b7741-50ac-5c4c-ac51-ea56d8cc4c46","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"a7e09ccb-6701-5658-a01c-52a02d7f9f80","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"a54b63f6-0b42-5584-91e8-027e613f7246","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"f6168c43-2e36-5e1d-bb44-04674d098b73","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"67399dd0-adb5-5b36-a616-cfc0605ebe52","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"9c30093e-b7fa-5c0f-84d0-465bf0768823","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"8f766fdc-ff98-5227-9d99-fe65802aaaca","slug":"definition","fullItemName":"Definition"},{"id":"4c33be40-568c-527a-8936-a79726b11e66","slug":"causes","fullItemName":"Causes"},{"id":"b8817533-a2e9-531b-9c51-d1c3da17b2ef","slug":"prevalence","fullItemName":"Prevalence"},{"id":"ea6fdfd8-a5f7-52de-ac19-8a05fd53556f","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"cdbbc165-3643-5f50-8f32-9fc5504ba2ef","slug":"complications","fullItemName":"Complications"},{"id":"59787aa9-8de0-5efd-b54e-2d72c75845a5","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"59e978dc-e4bc-574d-a047-413f87ec6b3d","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"ea4a531c-cf38-5e54-85d9-1f845bf7582f","slug":"when-to-suspect","fullItemName":"When to suspect"},{"id":"ebe23574-b6e5-5812-816c-6955392cee34","slug":"assessment","fullItemName":"Assessment"},{"id":"c501646c-c9a8-5372-ae9c-c0aab453c6e5","slug":"features-of-acute-limb-ischaemia","fullItemName":"Features of acute limb ischaemia"},{"id":"fdc33cb6-26a1-58c3-8eab-79d69745d871","slug":"features-of-intermittent-claudication-critical-limb-ischaemia","fullItemName":"Features of intermittent claudication and critical limb ischaemia"},{"id":"8c98aa45-6aef-5b47-a997-e9eeec827356","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"04fcdfca-c3cb-56b4-a18e-535c5a54e1a9","slug":"management","fullItemName":"Management","subChapters":[{"id":"fb3fcf0a-56a8-5693-b5ef-75e12c6f1f11","slug":"acute-limb-ischaemia","fullItemName":"Scenario: Acute limb ischaemia"},{"id":"d89d9e21-f892-533e-a3b8-e5649a205398","slug":"critical-limb-ischaemia","fullItemName":"Scenario: Critical limb ischaemia"},{"id":"357ee79f-9fa4-57e7-abd7-7881201f1629","slug":"intermittent-claudication","fullItemName":"Scenario: Intermittent claudication"}]},{"id":"da28584d-59b4-5a06-9357-9484a9bf93cc","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"e3ab00c1-43b9-58c7-a1c4-44198627e4ab","slug":"naftidrofuryl-oxalate","fullItemName":"Naftidrofuryl oxalate"},{"id":"bb79b6c3-de22-58b3-9244-5ae82a6133ad","slug":"paracetamol-weak-opioids","fullItemName":"Paracetamol and weak opioids"}]},{"id":"1545d985-832b-5a4a-abc9-bd7f0c21b754","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"049d6682-f78d-5c05-bdfb-1dbd5e91b017","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"58d7e6c5-f97f-507d-b627-87ab85bde479","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"574b8e96-33b9-5191-81dd-f415c704abf9","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"f3df8039-73c2-5c30-b7e8-2566977e32dc","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"d466274b-a2ab-58f1-badc-abfed7066e4f","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"aaed3513-3a59-5991-8410-2c4446539abd","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"74346084-c291-5a06-ac3d-a0ae85243940","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"fff7e03a-2313-5ab5-b744-9c6bba67aa6b"}},"staticQueryHashes":["3666801979"]}